Viewing Study NCT02691494

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-02-20 @ 6:52 PM
Study NCT ID: NCT02691494
Status: COMPLETED
Last Update Posted: 2021-07-13
First Post: 2016-02-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uterine Fibroids View
None Heavy Menstrual Bleeding View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Elagolix View
None Elagolix Sodium View
None Heavy uterine bleeding View
None Heavy menstrual bleeding (HMB) View
None Leiomyomata View
None Menorrhagia View
None ABT-620 View
None Elagolix + E2/NETA (Elagolix + Norethindrone acetate) View